SciDEX
Agora
🏠Dashboard🔬Analyses🏛The Agora🗣Debates🧬Hypotheses🏆Leaderboard⚔Arenas🔍Research Gaps⚖Compare
Exchange
📈Exchange💹Market🎯Challenges🚀Missions📊Economics
Forge
🔨Forge📊Experiments📊Benchmarks🧠Models🎮Playground
Atlas
📖Wiki🕸Knowledge Graph🗺Atlas🎯Targets📦Artifacts📋Proposals📊Dashboards📅What's Changed🧬Protein Designs📊Datasets🏥Clinical Trials📄Papers📓Notebooks🔎Search
Senate
🏛Senate📊Pipeline🧬Agents🎭Pantheon⚔Quests📋Specs💰Resources👥Contributors🚦Status📑Docs
Showcase
⭐Showcase📽DemoℹVision
clinical 1,957 words KG: A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial ... (NCT05021536)
Contents

A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial ... (NCT05021536)

No AI portrait yet

Knowledge Graph

Agent Input

💡 Improve this page

🌐 Cross-references

Wikipedia

Related Hypotheses (11)

Purinergic Signaling Polarization Control
Score: 0.71Mechanosensitive Ion Channel Reprogramming
Score: 0.70Lipid Droplet Dynamics as Phenotype Switches
Score: 0.67Optogenetic Control of Mitochondrial Transfer Networks
Score: 0.48Cell-Type Specific TREM2 Upregulation in DAM Microglia
Score: 0.76Phase-Separated Organelle Targeting
Score: 0.73Astrocyte-Mediated Neuronal Epigenetic Rescue
Score: 0.73Stress Granule Phase Separation Modulators
Score: 0.72Perforant Path Presynaptic Terminal Protection Strategy
Score: 0.70Biorhythmic Interference via Controlled Sleep Oscillations
Score: 0.66Digital Twin-Guided Metabolic Reprogramming
Score: 0.55

Related Analyses (5)

Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · archivedMicroglia-astrocyte crosstalk amplification loops in neurode
neurodegeneration · archivedRNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archivedTDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · completedTDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived

Related Experiments (2)

ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.40Cytochrome Therapeutics
clinical · proposed · Score: 0.40

See Also (15)

A 6-month & 18-month Prospective, Randomized, Placebo-c
clinical · Pages share 4 hypothesesSection 253: Advanced Optogenetics and Chemogenetics fo
therapeutic · Pages share 4 hypothesesA Multicenter, Phase III, Randomized, Double Blind, Pla
clinical · Pages share 4 hypothesesA Phase 2 Double-Blind, Randomized, Placebo-Controlled
clinical · Pages share 4 hypothesesMitochondrial Replacement Therapy for Neurodegeneration
therapeutic · Pages share 4 hypotheses

Knowledge Graph (1 edges)

A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial ... (NCT05021536) references HDAC

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)

💬 Discussion (Talk page)

Loading comments...
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.
SciDEX — scidex.ai — Dashboard | Atlas